{"transactions":[{"id":739123,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:15:50.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service to the Company through the applicable vesting date."}],"balance_after":28000,"derivative":{"exercise_price":4.34,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001628280-26-042859","document":"wk-form4_1781295346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723450/000162828026042859/wk-form4_1781295346.xml","form_type":"4"}},{"id":950387,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T21:04:43.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full upon stockholder approval of an increase in the share reserve under the Companys Amended and Restated 2017 Equity Incentive Plan at the Companys 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide services through such date."}],"balance_after":0,"derivative":{"exercise_price":4,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001501697-26-000005","document":"wk-form4_1767647080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000150169726000005/wk-form4_1767647080.xml","form_type":"4"}},{"id":1116041,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-10T20:30:52.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":7883,"source":{"system":"sec-edgar","filing":"0001628280-25-030504","document":"wk-form4_1749587446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828025030504/wk-form4_1749587446.xml","form_type":"4"}},{"id":1196671,"issuer":{"id":1161,"kind":"organization","name":"Camp4 Therapeutics Corp","symbol":"CAMP"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-19T16:07:33.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":17787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in equal monthly installments over a period of three years commencing from the date of grant."}],"balance_after":17787,"derivative":{"exercise_price":5.37,"expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":17787},"source":{"system":"sec-edgar","filing":"0001736730-25-000011","document":"wk-form4_1742414847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723450/000173673025000011/wk-form4_1742414847.xml","form_type":"4"}},{"id":1483093,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T20:13:02.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":191504,"source":{"system":"sec-edgar","filing":"0001628280-24-027675","document":"wk-form4_1718136772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024027675/wk-form4_1718136772.xml","form_type":"4"}},{"id":1809602,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-11T23:26:20.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":130056,"price":1.06,"value":137859.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":146504,"source":{"system":"sec-edgar","filing":"0001628280-23-029148","document":"wk-form4_1691796370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828023029148/wk-form4_1691796370.xml","form_type":"4"}},{"id":1809601,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-11T23:26:20.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":269893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired upon acceleration of the vesting of a performance-based restricted stock unit grant."}],"balance_after":276560,"source":{"system":"sec-edgar","filing":"0001628280-23-029148","document":"wk-form4_1691796370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828023029148/wk-form4_1691796370.xml","form_type":"4"}},{"id":2055940,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-13T01:03:08.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":182433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 9, 2023, the Reporting Person was granted 182,433 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the anniversary of the grant date of January 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":182433,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":182433},"source":{"system":"sec-edgar","filing":"0001562180-23-000403","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218023000403/primarydocument.xml","form_type":"4"}},{"id":2055939,"issuer":{"id":5970,"kind":"organization","name":"AMARIN CORP PLC\\UK"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-13T01:03:08.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":223560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 9, 2023, the Reporting Person was granted an option to purchase 223,560 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the \"Plan\"). The option shall vest and become exercisable in a single annual installment upon the one-year anniversary of the grant date of January 9, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":223560,"derivative":{"exercise_price":1.48,"expiration_date":"2033-01-09","underlying":"Ordinary Shares","underlying_shares":223560},"source":{"system":"sec-edgar","filing":"0001562180-23-000403","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897448/000156218023000403/primarydocument.xml","form_type":"4"}},{"id":2220924,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-27T20:15:51.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents unvested RSUs."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001628280-22-018050","document":"wf-form4_165636093576773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828022018050/wf-form4_165636093576773.xml","form_type":"4"}},{"id":2685950,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-02T21:03:22.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":6000,"price":9.5,"value":57000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 2, 2021, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":6000,"derivative":{"exercise_price":9.5,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-21-011544","document":"wf-form4_162266776504487.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828021011544/wf-form4_162266776504487.xml","form_type":"4"}},{"id":2858251,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-16T22:27:45.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date."}],"balance_after":56250,"derivative":{"exercise_price":30.66,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001104659-21-024413","document":"tm216849-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465921024413/tm216849-3_4seq1.xml","form_type":"4"}},{"id":2858250,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-16T22:27:45.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date"}],"balance_after":9375,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001104659-21-024413","document":"tm216849-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465921024413/tm216849-3_4seq1.xml","form_type":"4"}},{"id":3001974,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-21T20:58:31.000Z","date":"2020-10-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.3333% of the shares subject to the option shall vest on October 20, 2021, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":7.27,"expiration_date":"2030-10-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-014661","document":"wf-form4_160331389771325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020014661/wf-form4_160331389771325.xml","form_type":"4"}},{"id":3090639,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-02T20:06:11.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on June 30, 2022, provided that if the Reporting Person incurs a qualifying termination on or prior to June 30, 2022, the restricted stock units will vest in full immediately prior to such qualifying termination. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on June 30, 2022, provided that if the Reporting Person incurs a qualifying termination on or prior to June 30, 2022, the restricted stock units will vest in full immediately prior to such qualifying termination. The restricted stock units have no expiration date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-080538","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920080538/a4.xml","form_type":"4"}},{"id":3113016,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T12:26:04.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":3427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 10, 2020, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":3427,"derivative":{"exercise_price":8.69,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":3427},"source":{"system":"sec-edgar","filing":"0001628280-20-009234","document":"wf-form4_159187834596343.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020009234/wf-form4_159187834596343.xml","form_type":"4"}},{"id":3261869,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-19T21:23:34.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2020 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 14, 2020."}],"balance_after":88000,"derivative":{"exercise_price":17.87,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0001104659-20-022827","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920022827/a4.xml","form_type":"4"}},{"id":3567679,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T23:57:46.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":6854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.3333% of the shares subject to the option shall vest on March 29, 2020, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the award, subject the Reporting Person continuing to provide services through each such date. This option was granted automatically upon the Reporting Person's election to the Board of Directors of the Issuer."}],"balance_after":6854,"derivative":{"exercise_price":17.41,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":6854},"source":{"system":"sec-edgar","filing":"0000899243-19-009663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000089924319009663/doc4.xml","form_type":"4"}},{"id":3653105,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T21:08:36.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 13, 2019 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 13, 2019."}],"balance_after":60000,"derivative":{"exercise_price":29.78,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-19-009041","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919009041/a4.xml","form_type":"4"}},{"id":3787898,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-10-17T21:30:14.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (1) 25% on October 15, 2019, and (2) the remaining 75% in 12 equal quarterly installments."}],"balance_after":100000,"derivative":{"exercise_price":26.54,"expiration_date":"2028-10-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-18-062553","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465918062553/a4.xml","form_type":"4"}},{"id":4060947,"issuer":{"id":152369,"kind":"organization","name":"NOVELION THERAPEUTICS INC.","symbol":"NVLNF"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-14T07:01:53.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable in three equal annual installments on February 12, 2019, February 12, 2020, and February 12, 2021."}],"balance_after":45000,"derivative":{"exercise_price":4.44,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-18-009353","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827809/000110465918009353/a4.xml","form_type":"4"}},{"id":4149627,"issuer":{"id":152369,"kind":"organization","name":"NOVELION THERAPEUTICS INC.","symbol":"NVLNF"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-29T16:04:14.000Z","date":"2017-11-27","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award will vest and become exercisable in three equal annual installments beginning November 27, 2018."}],"balance_after":200000,"derivative":{"exercise_price":3.97,"expiration_date":"2027-11-27","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-17-070961","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/827809/000110465917070961/a4.xml","form_type":"4"}},{"id":4149626,"issuer":{"id":152369,"kind":"organization","name":"NOVELION THERAPEUTICS INC.","symbol":"NVLNF"},"owners":[{"id":38523,"kind":"person","name":"Stewart Murray","position":1,"cik":"0001723450","reported_name":"Stewart Murray","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President R&D"}}],"security":"Common Stock","published_at":"2017-11-29T16:04:14.000Z","date":"2017-11-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable pursuant to a grant of restricted stock units.  Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning November 27, 2018."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-17-070961","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/827809/000110465917070961/a4.xml","form_type":"4"}}]}